We are live on ! Find out more
BCM

Bayesian Capital Management Portfolio holdings

AUM $81.9M
1-Year Est. Return 26.59%
This Fund
S&P 500
This Quarter Est. Return
+7.51%
1 Year Est. Return
+26.59%
3 Year Est. Return
+112.98%
5 Year Est. Return
+129.77%
10 Year Est. Return
+1,146.62%
AUM
$167M
AUM Growth
+$61M
Cap. Flow
+$56.5M
Cap. Flow %
33.8%
Top 10 Hldgs %
8.63%
Holding
643
New
301
Increased
60
Reduced
24
Closed
258

Top Buys

Rank Stock Value
1
WMT icon
Walmart Inc
WMT
+$1.54M
2
DFS
Discover Financial Services
DFS
+$1.5M
3
AMZN icon
Amazon
AMZN
+$1.4M
4
DLTR icon
Dollar Tree
DLTR
+$1.34M
5
SJM icon
J.M. Smucker
SJM
+$1.3M

Top Sells

Rank Stock Value
1
GIS icon
General Mills
GIS
+$1.15M
2
LULU icon
lululemon athletica
LULU
+$968K
3
ACN icon
Accenture
ACN
+$935K
4
HRL icon
Hormel Foods
HRL
+$787K
5
XLNX
Xilinx Inc
XLNX
+$764K

Sector Composition

Rank Sector Weight
1 Technology 20.97%
2 Consumer Discretionary 20.33%
3 Industrials 12.79%
4 Consumer Staples 12.7%
5 Healthcare 8.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VNCE icon
376
Vince Holding Corp
VNCE
$77.7M
$55K 0.03%
+1,009
New +$58.9K
EXTR icon
377
Extreme Networks
EXTR
$3.92B
$52K 0.03%
+15,400
New +$52.7K
SVU
378
DELISTED
SUPERVALU Inc.
SVU
$47K 0.03%
+1,429
New +$49K
DNR
379
DELISTED
Denbury Resources, Inc.
DNR
$43K 0.03%
+11,900
New +$44.7K
VIVS
380
VivoSim Labs
VIVS
$1.36M
$42K 0.03%
+47
New +$31.5K
SYNC
381
DELISTED
Synacor, Inc.
SYNC
$36K 0.02%
+11,713
New +$29.5K
TOVX icon
382
Theriva Biologics
TOVX
$9.78M
$31K 0.02%
+2
New +$37.6K
CBK
383
DELISTED
Christopher & Banks Corporation
CBK
$31K 0.02%
+13,967
New +$32.4K
FUEL
384
DELISTED
Rocket Fuel Inc.
FUEL
$23K 0.01%
+10,500
New +$27.7K
CTIC
385
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$6K ﹤0.01%
1,620
-5,990
-79% -$27.5K
ABM icon
386
ABM Industries
ABM
$2.84B
-6,300
Closed -$204K
ACGL icon
387
Arch Capital
ACGL
$36.3B
-8,619
Closed -$204K
ACN icon
388
Accenture
ACN
$94.3B
-8,105
Closed -$935K
AEM icon
389
Agnico Eagle Mines
AEM
$73B
-7,249
Closed -$262K
AKAM icon
390
Akamai
AKAM
$16.4B
-11,379
Closed -$632K
ALGN icon
391
Align Technology
ALGN
$12B
-6,616
Closed -$481K
ALTO icon
392
Alto Ingredients
ALTO
$349M
-14,927
Closed -$70K
AMN icon
393
AMN Healthcare
AMN
$1.3B
-7,600
Closed -$255K
ANF icon
394
Abercrombie & Fitch
ANF
$4.41B
-8,200
Closed -$259K
ARCO icon
395
Arcos Dorados Holdings
ARCO
$1.75B
-10,745
Closed -$39K
ARMK icon
396
Aramark
ARMK
$15.2B
-25,900
Closed -$619K
ATEN icon
397
A10 Networks
ATEN
$2.41B
-13,900
Closed -$82K
AVY icon
398
Avery Dennison
AVY
$12.5B
-8,100
Closed -$584K
AXON
399
Axon Enterprise
AXON
$42.4B
-14,900
Closed -$292K
BGC icon
400
BGC Group
BGC
$5.65B
-15,959
Closed -$93K

Similar funds

Bayesian Capital Management's Q2 2016 Portfolio in Review

As of Q2 2016, Bayesian Capital Management held 643 positions worth $167M, up 58% from $106M the previous quarter. Its ten largest holdings account for 8.6% of the portfolio.

Bayesian Capital Management deployed $56.5M of net new capital in Q2 2016, opening 301 new positions and adding to 60 existing holdings. Its largest new stake was Walmart Inc: 66,510 shares worth $1.62M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 24% a quarter earlier, followed by Consumer Discretionary and Industrials.

On the sell side, the largest reduction was Sysco, an estimated $382K trimmed.

  • Bayesian Capital Management's largest Q2 2016 buy was Walmart Inc: 66,510 shares worth $1.62M.
  • Bayesian Capital Management added most to Cisco in Q2 2016, an estimated $881K increase.
  • Bayesian Capital Management's biggest Q2 2016 reduction was Sysco, cutting an estimated $382K.
  • Bayesian Capital Management fully exited General Mills in Q2 2016, selling an estimated $1.15M.
  • Bayesian Capital Management's ten largest holdings make up 8.6% of its $167M portfolio in Q2 2016.
  • Bayesian Capital Management opened 301 new positions and closed 258 in Q2 2016.
  • Bayesian Capital Management's portfolio value rose 58% quarter-over-quarter to $167M.

Based on Bayesian Capital Management's 13F filing for Q2 2016, filed 12 Aug 2016.